ENTRY       D05928                      Drug
NAME        Stiripentol (JAN/USAN/INN);
            Diacomit (TN)
PRODUCT     DIACOMIT (BIOCODEX)
FORMULA     C14H18O3
EXACT_MASS  234.1256
MOL_WEIGHT  234.2909
CLASS       Neuropsychiatric agent
             DG03199  Antiepileptic agent
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01639  CYP2C19 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
            Metabolizing enzyme inhibitor
             DG01634  CYP1A2 inhibitor
             DG01643  CYP2C9 inhibitor
             DG01933  CYP2C19 inhibitor
             DG01645  CYP2D6 inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
              DG01522  CYP3A4 inhibitor
REMARK      Therapeutic category: 1139
            ATC code: N03AX17
            Product: D05928<JP/US>
EFFICACY    Anticonvulsant, Antiepileptic
  DISEASE   Dravet syndrome [DS:H01818]
METABOLISM  Enzyme: CYP1A2 [HSA:1544], CYP2C19 [HSA:1557], CYP3A4 [HSA:1576]
INTERACTION CYP inhibition: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576], CYP2D6 [HSA:1565], CYP2C19 [HSA:1557], CYP2C9 [HSA:1559]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N03 ANTIEPILEPTICS
               N03A ANTIEPILEPTICS
                N03AX Other antiepileptics
                 N03AX17 Stiripentol
                  D05928  Stiripentol (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Anticonvulsants
              Anticonvulsants, Other
               Stiripentol
                D05928  Stiripentol (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               113  Antiepileptics
                1139  Others
                 D05928  Stiripentol (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               D05928  Stiripentol
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               D05928  Stiripentol
              DG01639  CYP2C19 substrate
               D05928  Stiripentol
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D05928  Stiripentol
             Metabolizing enzyme inhibitor
              DG01634  CYP1A2 inhibitor
               D05928  Stiripentol
              DG01643  CYP2C9 inhibitor
               D05928  Stiripentol
              DG01933  CYP2C19 inhibitor
               D05928  Stiripentol
              DG01645  CYP2D6 inhibitor
               D05928  Stiripentol
              DG02852  CYP3A/CYP3A4 inhibitor
               DG01522  CYP3A4 inhibitor
                D05928  Stiripentol
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               D05928  Stiripentol
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D05928
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D05928
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D05928
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D05928
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D05928
DBLINKS     CAS: 137767-55-6 49763-96-4
            PubChem: 47207586
            LigandBox: D05928
            NIKKAJI: J10.374H
ATOM        17
            1   C8y C    16.0300  -17.9200
            2   C8y C    16.0300  -19.3200
            3   C8x C    17.2424  -20.0200
            4   C8x C    18.4549  -19.3200
            5   C8y C    18.4549  -17.9200
            6   C8x C    17.2424  -17.2200
            7   O2x O    14.6985  -17.4874
            8   C1x C    13.8756  -18.6200
            9   O2x O    14.6985  -19.7526
            10  C2b C    19.6860  -17.2090
            11  C2b C    20.8912  -17.9047
            12  C1c C    22.0735  -17.2219
            13  C1d C    23.2675  -17.9112
            14  O1a O    22.0735  -15.8202
            15  C1a C    24.4799  -18.6112
            16  C1a C    22.5571  -19.1422
            17  C1a C    23.9565  -16.7172
BOND        18
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 1
            9     8   9 1
            10    2   9 1
            11    5  10 1
            12   10  11 2
            13   11  12 1
            14   12  13 1
            15   12  14 1
            16   13  15 1
            17   13  16 1
            18   13  17 1
///
